Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Neurofibrosarcoma × metarrestin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1 Neurofibrosarcoma 1 Colorectal Neoplasms 1

Interventions

selinexor 2 Magnetic Resonance Spectroscopy 2 Doxorubicin 2 ribociclib 1 pembrolizumab 1 pegfilgrastim 1 metarrestin 1 ixazomib 1 fludarabine phosphate 1 fludarabine 1 cixutumumab 1 X-Rays 1 Specimen Handling 1 Photons 1 Mesna 1 Ifosfamide 1 High-Energy Shock Waves 1 Filgrastim 1 Cyclophosphamide 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04222413 2026-03-13

Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors

National Institutes of Health Clinical Center (CC)

Phase 1 Recruiting

GastrointestinalSarcoma

Pancreatic Neoplasms, Colorectal Neoplasms, Neurofibrosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡